ketanserin has been researched along with 2,5-dimethoxy-4-bromoamphetamine, (r)-isomer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glennon, RA; Herrick-Davis, K; Lyon, RA; Seggel, MR; Soine, WH; Titeler, M | 1 |
| Glennon, RA | 2 |
| Glennon, RA; Mosier, PD; Roth, BL; Runyon, SP; Westkaemper, RB | 1 |
1 review(s) available for ketanserin and 2,5-dimethoxy-4-bromoamphetamine, (r)-isomer
| Article | Year |
|---|---|
Central serotonin receptors as targets for drug research.
Topics: Animals; Humans; Receptors, Serotonin; Research Design; Serotonin | 1987 |
3 other study(ies) available for ketanserin and 2,5-dimethoxy-4-bromoamphetamine, (r)-isomer
| Article | Year |
|---|---|
[125I]-1-(2,5-dimethoxy-4-iodophenyl)-2-amino-propane: an iodinated radioligand that specifically labels the agonist high-affinity state of 5-HT2 serotonin receptors.
Topics: Amphetamines; Indicators and Reagents; Iodine Radioisotopes; Kinetics; Radioligand Assay; Receptors, Serotonin | 1988 |
Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation.
Topics: Animals; Anthracenes; Cattle; Humans; Ligands; Models, Molecular; Molecular Sequence Data; Molecular Structure; Mutagenesis; Protein Binding; Receptor, Serotonin, 5-HT2A; Sequence Alignment; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Structure-Activity Relationship | 2008 |
The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The "Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.
Topics: Animals; Central Nervous System Stimulants; Chemistry, Pharmaceutical; Dopamine; Drug Discovery; Hallucinogens; Humans; Illicit Drugs; Norepinephrine; Phenethylamines; Psychotropic Drugs; Receptors, Serotonin; Serotonin | 2017 |